David Simon outlines the procedures to manage anti-corruption risk that life sciences companies should consider before doing business in China.
David Simon, John Turlais, Kate Shoemaker, Nathan Kaiser & Jonathan Xi
Advertisement
David Simon is Partner, John Turlais is special counsel and a litigation lawyer, and Kate Shoemaker is an associate and litigation attorney, all at Foley & Lardner LLP. Nathan Kaiser is Partner and Jonathan Xi is Associate at Eiger Law.
Articles by David Simon, John Turlais, Kate Shoemaker, Nathan Kaiser & Jonathan Xi
Advertisement
Latest Updated Articles
Compliance in China: Key ConsiderationsPublished: January 29th 2018 | Updated:
Advertisement
Advertisement
